174 related articles for article (PubMed ID: 6958308)
1. Complement-dependent cytotoxicity of anti-human osteogenic sarcoma monoclonal antibodies.
Price MR; Pimm MV; Baldwin RW
Br J Cancer; 1982 Oct; 46(4):601-10. PubMed ID: 6958308
[TBL] [Abstract][Full Text] [Related]
2. In vivo localization of anti-osteogenic sarcoma 791T monoclonal antibody in osteogenic sarcoma xenografts.
Pimm MV; Embleton MJ; Perkins AC; Price MR; Robins RA; Robinson GR; Baldwin RW
Int J Cancer; 1982 Jul; 30(1):75-85. PubMed ID: 6956558
[No Abstract] [Full Text] [Related]
3. Localization of anti-osteogenic sarcoma monoclonal antibody 791T/36 in a primary human osteogenic sarcoma and its subsequent xenograft in immunodeprived mice.
Pimm MV; Perkins AC; Armitage NC; Baldwin RW
Cancer Immunol Immunother; 1985; 19(1):18-21. PubMed ID: 3856475
[TBL] [Abstract][Full Text] [Related]
4. Experience in the preparation and experimental use of immunocytostatics.
Embleton MJ; Pimm MV; Garnett MC; Rowland GF; Simmonds RG; Baldwin RW
Behring Inst Mitt; 1984 May; (74):108-12. PubMed ID: 6591915
[TBL] [Abstract][Full Text] [Related]
5. Differentiation between monoclonal antibody-defined antigens on a human osteogenic sarcoma cell line (791T) and tumor-localizing properties of the anti-791T/36 antibody.
Dawood F; Embleton MJ; Price MR; Pimm MV; Byers VS; Baldwin RW
Braz J Med Biol Res; 1986; 19(2):257-69. PubMed ID: 3470084
[TBL] [Abstract][Full Text] [Related]
6. Interferon-alpha conjugation to human osteogenic sarcoma monoclonal antibody 791T/36.
Pelham JM; Gray JD; Flannery GR; Pimm MV; Baldwin RW
Cancer Immunol Immunother; 1983; 15(3):210-6. PubMed ID: 6577942
[TBL] [Abstract][Full Text] [Related]
7. Antitumor monoclonal antibodies for radioimmunodetection of tumors and drug targeting.
Baldwin RW; Pimm MV
Cancer Metastasis Rev; 1983; 2(1):89-106. PubMed ID: 6352009
[TBL] [Abstract][Full Text] [Related]
8. Antibodies against osteosarcoma and colon cancer.
Embleton MJ; Brown A; Gunn B; Byers VS; Baldwin RW
Behring Inst Mitt; 1984 May; (74):35-8. PubMed ID: 6591916
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies for radioimmunodetection of tumours and for targeting.
Baldwin RW; Embleton MJ; Pimm MV
Bull Cancer; 1983; 70(2):132-6. PubMed ID: 6575842
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulation: NK cells activated by interferon-conjugated monoclonal antibody against human osteosarcoma.
Flannery GR; Pelham JM; Gray JD; Baldwin RW
Eur J Cancer Clin Oncol; 1984 Jun; 20(6):791-8. PubMed ID: 6589163
[TBL] [Abstract][Full Text] [Related]
11. Identification of an anti-human osteogenic sarcoma monoclonal-antibody-defined antigen on mitogen-stimulated peripheral blood mononuclear cells.
Price MR; Campbell DG; Baldwin RW
Scand J Immunol; 1983 Nov; 18(5):411-20. PubMed ID: 6359372
[TBL] [Abstract][Full Text] [Related]
12. Quantitative evaluation of the localization of a monoclonal antibody (791T/36) in human osteogenic sarcoma xenografts.
Pimm MV; Baldwin RW
Eur J Cancer Clin Oncol; 1984 Apr; 20(4):515-24. PubMed ID: 6586422
[TBL] [Abstract][Full Text] [Related]
13. Syngeneic anti-idiotypic antibody prevents localization of a murine monoclonal antibody in human tumour xenografts.
Pimm MV; Baldwin RW
Eur J Cancer; 1990; 26(5):567-8. PubMed ID: 2144742
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of two anti-tumour monoclonal antibody preparations.
Price MR; Dennick RG; Fang CY; Hannant D; Embleton MJ; Gunn B; Baldwin RW
Arch Geschwulstforsch; 1981; 51(4):302-9. PubMed ID: 6947720
[TBL] [Abstract][Full Text] [Related]
15. Antigenicity and drug susceptibility of human osteogenic sarcoma cells "escaping" a cytotoxic methotrexate-albumin-monoclonal antibody conjugate.
Embleton MJ; Garnett MC; Jacobs E; Baldwin RW
Br J Cancer; 1984 May; 49(5):559-65. PubMed ID: 6586198
[TBL] [Abstract][Full Text] [Related]
16. Antitumour reactions of monoclonal antibody against a human osteogenic-sarcoma cell line.
Embleton MJ; Gunn B; Byers VS; Baldwin RW
Br J Cancer; 1981 May; 43(5):582-7. PubMed ID: 6941806
[TBL] [Abstract][Full Text] [Related]
17. Demonstration of natural antibodies in normal rabbit serum with similar specificity pattern as mouse natural killer cells.
Grönberg A; Hansson M; Kiessling R; Andersson B; Kärre K; Roder J
J Natl Cancer Inst; 1980 May; 64(5):1113-9. PubMed ID: 6966004
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody targeting of methotrexate (MTX) against MTX-resistant tumour cell lines.
Affleck K; Embleton MJ
Br J Cancer; 1992 Jun; 65(6):838-44. PubMed ID: 1616855
[TBL] [Abstract][Full Text] [Related]
19. Conjugates of monoclonal antibody 791T/36 with methotrexate in cancer therapy.
Baldwin RW; Embleton MJ; Garnett MC; Pimm MV
NCI Monogr; 1987; (3):95-9. PubMed ID: 3469528
[TBL] [Abstract][Full Text] [Related]
20. Localization of an anti-CEA monoclonal antibody in colo-rectal carcinoma xenografts.
Pimm MV; Armitage NC; Perkins AC; Smith W; Baldwin RW
Cancer Immunol Immunother; 1985; 19(1):8-17. PubMed ID: 3844977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
